Enhancing Mechanistic Research on Precision Probiotic Therapies |
PAR-25-211 (R61/R33 Clinical Trial Optional) |
R61, R33 |
Clinical Trial Optional |
06/03/2027 |
Gabriela Riscuta, M.D., CNS |
NIH Support for Conferences and Scientific Meetings |
PA-25-080 (Parent R13 Clinical Trial Not Allowed) |
R13 |
Clinical Trial Not Allowed |
09/08/2027 |
Asad Umar, D.V.M., Ph.D. |
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research |
PAR-25-248 (U01 Clinical Trial Not Allowed) |
U01 |
Clinical Trial Not Allowed |
10/09/2027 |
Claire Zhu, Ph.D. |
Cancer Prevention and Control Clinical Trials Planning Grant Program |
PAR-25-104 (R34 Clinical Trials Optional) |
R34 |
|
10/26/2027 |
Goli Samimi, Ph.D., M.P.H. |
Cancer Prevention and Control Clinical Trials Planning Grant Program |
PAR-25-103 (U34 Clinical Trials Optional) |
U34 |
|
10/26/2027 |
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Mechanisms that Impact Cancer Risk after Bariatric Surgery |
PAR-25-043 (R01 Clinical Trial Optional) |
R01 |
Clinical Trial Optional |
01/08/2028 |
Edward Sauter, M.D., Ph.D. |
Mechanisms that Impact Cancer Risk after Bariatric Surgery |
PAR-25-044 (R21 Clinical Trial Not Allowed) |
R21 |
Clinical Trial Not Allowed |
01/08/2028 |
Edward Sauter, M.D., Ph.D. |
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies |
PAR-25-145 (R01 Clinical Trial Optional) |
R01 |
Clinical Trial Optional |
01/08/2028 |
Rachel Altshuler, Ph.D. |
NIH Research Project Grant |
PA-25-301 (Parent R01 Clinical Trial Not Allowed) |
R01 |
Clinical Trial Not Allowed |
01/08/2028 |
Asad Umar, D.V.M., Ph.D. |